Evolva is looking for a highly qualified individual for the key position of Chief Medical Officer.
Evolva's proprietary discovery technology platform uses a “disruptive” technological approach to the creation of novel small compounds that differs sharply from the prevailing synthetic chemistry and protein engineering approaches in the pharmaceutical industry today. Based on this technology, Evolva has a number of discovery and pre-clinical partnerships which in 2009 generated revenues of CHF 18.9 million. Evolva also has an attractive pipeline of compounds – one drug candidate (for renal and cardiovascular diseases) is in Phase I and two others (an anti-fungal and an anti-viral) are in late preclinical stages. Evolva is listed on the SIX Swiss Exchange with the ticker EVE. For more information see www.evolva.com.
Evolva is seeking a Chief Medical Officer with strong experience in anti-infectives and/or cardiovascular diseases. The position will be in Basel.
Your responsibilities will include:
The ideal candidate should be a Medical Doctor and have experience in positions of increasing clinical development responsibility within big pharma/biotech. Other desirable qualifications and characteristics include:
For further information please contact:
Neil Goldsmith, CEO on +41 61 485 2000
Please send your application together with relevant documentation by e-mail to recruitment@evolva.com or by ordinary mail to:
Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland